Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07228130 · ClinicalTrials.gov registry record · NA

Microrandomized Trial to Optimize Use of Burden-reducing Self-monitoring Approaches in Behavioral Obesity Treatment

A NA study of Obesity & Overweight, sponsored by The Miriam Hospital.

Recruiting
Registry status
NA
Development phase
275
Enrollment target
1
Study location

NCT07228130: Recruiting NA study of Obesity & Overweight, sponsored by The Miriam Hospital.

NCT07228130 is a NA study of Obesity & Overweight that is actively recruiting participants, run by The Miriam Hospital. The registered enrollment target is 275 participants, above the 105-participant average among 28 other Obesity & Overweight trials with a reported enrollment target (162% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07228130, a NA study of Obesity & Overweight, is actively recruiting participants, sponsored by The Miriam Hospital.

RECRUITING
Registry status
NA
Development phase
275 participants
Enrollment target
1
Study location

Study Summary

This clinical trial is focused on testing dietary self-monitoring strategies used in behavioral obesity treatment. The goal is to determine which self-monitoring strategies are most useful for whom, at which points in treatment, and under what circumstances. Researchers will provide a 24-week online behavioral obesity treatment program, and will randomize participants to use one of 5 dietary self-monitoring strategies every two weeks. The five strategies include: recording all food and drink consumed and corresponding energy intake (i.e., "calories") on 7 days per week; recording all food and drink consumed and corresponding energy intake (i.e., "calories") on 3 days per week; self-monitoring of dietary lapses (i.e. any eating/drinking likely to cause weight gain or put weight loss at risk); smartwatch-based monitoring of energy intake (i.e., "calories"); and self-monitoring of body weight only via smart scale. Participants will: * Follow a 24-week online program for weight loss and health improvement * Use the assigned self-monitoring strategy every two weeks * Meet with the researchers periodically via online video call and provide research data by answering questions via periodic online surveys.

Primary Outcome

Number of days on which the assigned self-monitoring strategy was used

Conditions Studied

Interventions

  • BEHAVIORAL Online Behavioral Obesity Treatment
  • BEHAVIORAL Full Dietary Self-monitoring
  • BEHAVIORAL Reduced-frequency Dietary Self-monitoring
  • BEHAVIORAL Self-Monitoring of Dietary Lapses Only
  • BEHAVIORAL Smartwatch-based Self-monitoring of Energy Intake

Study Locations (1)

Rhode Island

  • The Weight Control and Diabetes Research Center of The Miriam Hospital & Brown University - Providence

Trial Details

FieldValue
Enrollment Target 275 participants
Start Date 2026-01-07
Est. Completion 2029-03-01
Phase NA
The Miriam Hospital

136 total trials

What NCT07228130 shows while recruiting

NCT07228130 is an interventional study that assigns participants to a tested intervention. The registered 275 participants enrollment target is mid-sized for trials with a published cap, above the 105-participant average among 28 other Obesity & Overweight trials with a reported enrollment target (162% higher).

The record links to 1 condition, with Obesity & Overweight appearing as the primary indexed condition, and to 5 interventions - of which Online Behavioral Obesity Treatment is the first listed.

NCT07228130 reports a single indexed study location in Rhode Island.

Frequently Asked Questions

What is clinical trial NCT07228130 about?

NCT07228130 is a clinical study titled "Microrandomized Trial to Optimize Use of Burden-reducing Self-monitoring Approaches in Behavioral Obesity Treatment". This clinical trial is focused on testing dietary self-monitoring strategies used in behavioral obesity treatment. The goal is to determine which self-monitoring strategies are most useful for whom, at which points in treatment, and under what circumstances. Researchers will provide a 24-week onlin...

What is the current status of trial NCT07228130?

This trial is currently recruiting. It is a NA study. The enrollment target is 275 participants. The study started on 2026-01-07. Estimated completion is 2029-03-01.

What conditions does trial NCT07228130 study?

This clinical trial studies the following conditions: Obesity & Overweight.

What interventions are being tested in trial NCT07228130?

The interventions under investigation include: Online Behavioral Obesity Treatment (BEHAVIORAL), Full Dietary Self-monitoring (BEHAVIORAL), Reduced-frequency Dietary Self-monitoring (BEHAVIORAL), Self-Monitoring of Dietary Lapses Only (BEHAVIORAL), Smartwatch-based Self-monitoring of Energy Intake (BEHAVIORAL).

Who is sponsoring clinical trial NCT07228130?

This trial is sponsored by The Miriam Hospital, which has 136 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07228130 being conducted?

This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity & Overweight

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07228130's enrollment target sits among peer trials

275 4th of 28 higher than 25 of 28 other Obesity & Overweight trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity & Overweight trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01269190 · 275 participants · NA

    Wide-Field and High Resolution In Vivo Imaging in Visualizing Lesions in Patients With Oral Neoplasia Undergoing Surgery

  • NCT01900132 · 275 participants · NA

    Electrical Impedance Myography: Natural History Studies inNeuromuscular Disorders and Healthy Volunteers

  • NCT04104776 · 275 participants · Phase 1

    A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

  • NCT04765150 · 275 participants

    Integrating Quantitative MRI and Artificial Intelligence to Improve Prostate Cancer Classification

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07228130, the US trial registry maintained by the National Library of Medicine. NCT07228130 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.